Private equity-backed cardiology group continues busy year with acquisition of Florida practice

Cardiovascular Associates of America (CVAUSA), a Florida-based practice management company operated by Webster Equity Partners, has acquired Bay Area Cardiology and Vascular Associates (BACVA), a Florida practice with four locations and 15 cardiologists.

BACVA has been in business for more than three decades and operates locations in Brandon, Sun City Center, Riverview and Tampa, Florida. In addition to performing echocardiograms, electrocardiograms, nuclear stress tests and other cardiac imaging exams, physicians at BACVA also specialize in the treatment of vascular complications such as deep vein thrombosis and varicose veins.

“Bay Area Cardiology and Vascular Associates is excited to partner with CVAUSA as we continue to expand our ability to provide cutting edge, high quality and high value cardiovascular care in the Tampa Bay area,” Stephen Mester, MD, managing partner of BACVA, said in a prepared statement highlighting the deal. “BACVA also provides a fully accredited Cardiology fellowship training program to help meet the expanding demand for cardiovascular services in our communities.  We look forward to drawing on the strengths of the CVAUSA team, which will allow us to continue to develop and implement improved methods of excellent and efficient cardiovascular care.”

This represents the third time in 2023 CVAUSA, which has its headquarters in Orlando, has added a Florida-based practice to its network. The company acquired the Cardiovascular Institute of Central Florida in February and the Cardiac and Vascular Institute in April. CVAUSA also announced the addition of New Jersey-based Shore Heart Group to its network just weeks ago.  

“It’s a tremendous honor to partner with the outstanding physicians and staff at BACVA,” Tim Attebery, CVAUSA’s CEO, said in the same statement. “They are 'the' leading cardiovascular group in the greater Tampa Bay area. I look forward to working with BACVA over the coming years as they add more physicians and expand their footprint of offices and ambulatory services. They have built a strong foundation with excellent clinicians, a great culture, a reputation for service and quality, highly skilled and passionate staff, and a scalable infrastructure.”

Cardiovascular Business spoke with Attebery in February about the continued rise of private equity in cardiology. Read the full interview here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.